Bausch Health (BHC) 8-K Form Query Results and Company Information as of March 1, 2024

After multiple searches, I

. This may be due to one of the following reasons:

1. No 8-K form was filed on that date
2. The filing date may be inaccurate
3. The document may not be fully indexed in public databases

Based on the company data I obtained [0], here are key details about the company:

• Company Name
  : Bausch Health Companies Inc.
• Stock Ticker
  : NYSE/TSX: BHC
• Industry
  : Healthcare - Pharmaceuticals (Specialty and Generic Drugs)
• Market Capitalization
  : Approximately $2.67 billion
• Current Stock Price
  : $7.21

Indicator	Value
Price-to-Earnings Ratio (P/E)	7.39x
Net Profit Margin	4.38%
Operating Profit Margin	22.97%
Current Ratio	1.30
Return on Equity (ROE)	-38.20%

Business Segment	Revenue	Proportion
Pharmaceutical Products	$4.40 billion	45.7%
Device Products	$2.24 billion	23.3%
Over-the-Counter Products	$1.90 billion	19.8%
Branded and Other Generic Drugs	$979 million	10.2%

Based on search results, I found the following relevant information:

1. March 1, 2024 Press Release
   [2]: The company announced that management will participate in the Cowen Annual Healthcare Conference in Boston on March 5, 2024, and host a fireside chat.

2. Board Changes
   : According to Bausch + Lomb’s proxy statement [1], Ms. Karen L. Ling was appointed to the company’s board of directors on February 27, 2024, and this information was disclosed to the SEC via an 8-K form on February 28, 2024.

If you need to obtain the specific content of the March 1, 2024 8-K form, it is recommended to:

1. Visit the SEC EDGAR System Directly
   :
   • Visit https://www.sec.gov/edgar/searchedgar/companysearch.html
   • Search for the company’s CIK number: 0000885590
   • Filter for 8-K documents from March 2024

2. Visit the Company’s Investor Relations Page
   :
   • SEC filings page on Bausch Health’s investor relations website

3. Verify the Exact Date
   :
   • Confirm the exact filing date of the 8-K form
   • It may be February 28 or another date in early March

[1] SEC.gov - Bausch + Lomb Corporation Proxy Statement (https://www.sec.gov/Archives/edgar/data/1860742/000114036125013244/ny20040956x771_def14a.htm)

[2] Bausch Health Investors Relations - Cowen Conference Announcement (https://ir.bauschhealth.com/news-releases/2024/03-01-2024)

[0] Jinling API Data

: Since the full content of this specific 8-K form cannot be directly obtained, the above information is based on available public data and search results. It is recommended to verify specific information through the SEC EDGAR system or the company’s official channels.